Product Information
PHENOBARBITAL 30 MG TABLET is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.1284 per EA under NDC 00143150005. Its NADAC has been published 299 times since Oct 7, 2020.
Strength
30 mg/1
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00143150005
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PHENOBARBITALApproval Type
Unapproved
On Market Since
3/5/2020
Price Statistics
The NADAC for PHENOBARBITAL 30 MG TABLET has been published 299 times since Oct 7, 2020, and over the history we have for it it has declined 36.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1284 per EA |
|---|---|
| All-time high | $0.2632 (Sep 15, 2021) |
| All-time low | $0.0913 (Nov 20, 2024) |
| 52-week high | $0.1735 |
| 52-week low | $0.1284 |
| Median price | $0.1767 |
| Average price | $0.1802 |
| Largest weekly change | -45.1% (Nov 20, 2024) |
| Weeks tracked | 299 |
| Tracking since | Oct 7, 2020 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PHENOBARBITAL 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PHENOBARBITAL 30 MG TABLET, manufactured by Hikma Pharmaceuticals USA Inc., is $0.1284 per EA (NDC 00143150005), effective Jun 24, 2026.
How has the price of PHENOBARBITAL 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for PHENOBARBITAL 30 MG TABLET has declined 36.4%. It has been tracked across 299 weekly CMS publications since Oct 7, 2020.
What are the highest and lowest recorded NADAC prices for PHENOBARBITAL 30 MG TABLET?
Since Oct 7, 2020, the NADAC for PHENOBARBITAL 30 MG TABLET has ranged from a low of $0.0913 (Nov 20, 2024) to a high of $0.2632 (Sep 15, 2021), with a median of $0.1767 per EA.
Are there cheaper alternatives to PHENOBARBITAL 30 MG TABLET?
5 NADAC-published products share the same active ingredient, strength, and dosage form as PHENOBARBITAL 30 MG TABLET, but none are currently priced below it.
Who manufactures PHENOBARBITAL 30 MG TABLET?
PHENOBARBITAL 30 MG TABLET (NDC 00143150005) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification